ADHD & Cognitive Performance Optimization

About This Condition

Attention deficit hyperactivity disorder (ADHD) affects approximately 8% of children and 4–5% of adults in the United States, though adult ADHD is significantly underdiagnosed — particularly in women, who often present with predominantly inattentive symptoms that are missed by hyperactivity-focused screening tools. Beyond clinical ADHD, a broader population of high-performing individuals seeks cognitive optimization: improved focus, working memory, processing speed, and executive function. Both populations are often underserved — those with ADHD by delayed diagnosis and medication-only management, and the optimization-focused by a conventional medicine system that has no framework for it.

Our Approach

For adults presenting with attention and cognitive concerns, we perform structured screening (ASRS, Conners Adult ADHD Rating Scale) and evaluate the biological contributors that amplify or mimic ADHD: thyroid dysfunction, iron deficiency (serum ferritin <50 ng/mL impairs dopamine synthesis), vitamin D deficiency, sleep disorders, testosterone deficiency, and chronic stress with cortisol dysregulation. We prescribe and manage stimulant medications (amphetamine and methylphenidate-based) when indicated, with appropriate monitoring. For cognitive optimization, we develop individualized nootropic and nutraceutical protocols: omega-3 (DHA-forward), lion's mane mushroom, bacopa monnieri, phosphatidylserine, and citicoline — with the understanding that stimulants are tools, not cures, and that substrate optimization underlies peak cognitive function.